Literature DB >> 32476897

Relationship of emotional distress and physical concerns with fatigue severity in sarcoidosis.

Pawel Holas1, Joachim Kowalski1, Anna Dubaniewicz2, Malgorzata Farnik3, Agnieszka Jarzemska4, Marta Maskey-Warzechowska5, Maksymilian Bielecki6, Joanna Domagala-Kulawik5.   

Abstract

Background: Fatigue is one of the most common and disabling symptoms of sarcoidosis. The cause of fatigue remains unclear and is usually multifactorial. The majority of previous studies evaluated clinical parameters with only few of them including assessment of psychological factors as contributing to the severity of the symptoms. Objective: The aim of this study was to evaluate the relationship of emotional distress, physical concerns, and dyspnea in explaining fatigue in patients with sarcoidosis.
Methods: Fifty-seven patients with sarcoidosis were enrolled to the study and filled out measures of fatigue (FAS), dyspnea (MRC), anxiety sensitivity (ASI-3), and anxiety and depression (HADS).
Results: Linear regression revealed that distress and physical concerns subscale of ASI are significant predictors of fatigue explaining jointly 53.5% of fatigue variance. Conclusions: The results of the study emphasize the importance of including emotional distress and physical concerns into the diagnostic procedures and management of fatigue in sarcoidosis. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 160-164). Copyright:
© 2018.

Entities:  

Keywords:  anxiety; anxiety sensitivity; dyspnea; fatigue; physical concerns; sarcoidosis

Year:  2018        PMID: 32476897      PMCID: PMC7170092          DOI: 10.36141/svdld.v35i2.6604

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  22 in total

Review 1.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

2.  Fatigue is associated with quality of life in sarcoidosis patients.

Authors:  Helen J Michielsen; Marjolein Drent; Tatjana Peros-Golubicic; Jolanda De Vries
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

3.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Authors:  J C Bestall; E A Paul; R Garrod; R Garnham; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

4.  Depression in sarcoidosis.

Authors:  B Chang; J Steimel; D R Moller; R P Baughman; M A Judson; H Yeager; A S Teirstein; M D Rossman; C S Rand
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

Review 5.  Latent structure of the Hospital Anxiety And Depression Scale: a 10-year systematic review.

Authors:  Theodore D Cosco; Frank Doyle; Mark Ward; Hannah McGee
Journal:  J Psychosom Res       Date:  2011-09-14       Impact factor: 3.006

6.  Health-related quality of life of persons with sarcoidosis.

Authors:  Christopher E Cox; James F Donohue; Cynthia D Brown; Yash P Kataria; Marc A Judson
Journal:  Chest       Date:  2004-03       Impact factor: 9.410

7.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3.

Authors:  Steven Taylor; Michael J Zvolensky; Brian J Cox; Brett Deacon; Richard G Heimberg; Deborah Roth Ledley; Jonathan S Abramowitz; Robert M Holaway; Bonifacio Sandin; Sherry H Stewart; Meredith Coles; Winnie Eng; Erin S Daly; Willem A Arrindell; Martine Bouvard; Samuel Jurado Cardenas
Journal:  Psychol Assess       Date:  2007-06

9.  Anxiety and depression in sarcoidosis: the influence of age, gender, affected organs, concomitant diseases and dyspnea.

Authors:  A Hinz; E Brähler; R Möde; H Wirtz; A Bosse-Henck
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2012-10       Impact factor: 0.670

10.  Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS).

Authors:  Jolanda De Vries; Helen Michielsen; Guus L Van Heck; Marjolein Drent
Journal:  Br J Health Psychol       Date:  2004-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.